Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 2Stomatitis 1Neoplasms 1Neoplasm Metastasis 1Lupus Nephritis 1Lung Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia 1Inflammation 1Fatigue Syndrome, Chronic 1Bone Neoplasms 1Bites and Stings 1Arthritis, Rheumatoid 1

Interventions

Cyclophosphamide 9Mycophenolic Acid 8Filgrastim 7Cyclosporine 7fludarabine phosphate 6Methotrexate 6Busulfan 6Antilymphocyte Serum 6Cord Blood Stem Cell Transplantation 5Tacrolimus 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4thymoglobulin 3Methylprednisolone 3Granulocyte Colony-Stimulating Factor 3Cytarabine 3Clofarabine 3Rituximab 2Etoposide 2Amplified Fragment Length Polymorphism Analysis 2plerixafor 1fludarabine 1aldesleukin 1Whole-Body Irradiation 1Topotecan 1Thiotepa 1Stem Cell Transplantation 1Mitoxantrone 1Isotretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myelomonocytic, Juvenile × Etanercept × Clear all
NCT00509600 2012-08-07

Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 5 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡